Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000353342

Medchemexpress LLC Rogocekib (CTX-712) | 2144751-78-8 | 98.2% | C19H17FN8O2 | 100 MG
SDP

Catalog No. 5000353342
Encompass_Preferred

Rogocekib is an orally effective CLK 2 inhibitor with an IC50 of 1.4 nM, demonstrating anti-tumor activity. It is for research use only.

  • Strong inhibitory effect on the proliferation of human myeloid K562 and MV-4-11 cells
  • Exhibits anti-leukemia activity in primary acute myeloid leukemia (AML) cells
  • Inhibits the phosphorylation of various serine/arginine (SR) proteins
  • Reduces tumor size and increases survival rates in mouse models of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)

Catalog No. 50-003-53342 Supplier Medchemexpress LLC Supplier No. HY144875100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Rogocekib is an orally effective CLK 2 inhibitor with an IC50 of 1.4 nM, demonstrating anti-tumor activity. It is for research use only.

  • Strong inhibitory effect on the proliferation of human myeloid K562 and MV-4-11 cells
  • Exhibits anti-leukemia activity in primary acute myeloid leukemia (AML) cells
  • Inhibits the phosphorylation of various serine/arginine (SR) proteins
  • Reduces tumor size and increases survival rates in mouse models of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.